Lyell Immunopharma, Inc. · NASDAQ:LYEL
EULER FUND, L.P. reported a 6.71% stake in Lyell Immunopharma, Inc. (Schedule 13G)
Event Mar 6, 2026 · Filed Apr 21, 2026
EULER FUND, L.P. reported a 6.71% stake in Lyell Immunopharma, Inc., 1,426,528 shares, as a passive investor on Mar 6, 2026. Filed Apr 21, 2026 (Schedule 13G).
- Stake
- 6.71%
- Shares
- 1,426,528
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EULER FUND, L.P. | 6.71% | 1,426,528 |
| Euler Managers Limited | 6.71% | 1,426,528 |
| Antonis Indianos | 6.71% | 1,426,528 |